AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy

Article Abstract:

The authors points to the fact that, since introduction of highly active antiretroviral therapy (HAART) non-Hodgkin's lymphoma (NHL) has declined, but not as much as other AIDS-related illnesses. He posits the possibility that this may be so for a variety of reasons including the fact that NHL is not the result of a single organism, and also that NHL is often found at an earlier stage of immunodeficiency than other diseases and therefore partial immune recovery as a result of HAART may not be enough to prevent NHL.

Non-Hodgkin's lymphomas, Highly active antiretroviral therapy, AIDS-related complex

---

Developing immunotherapeutic strategies for the control of Epstein-Barr virus -- associated malignancies

Article Abstract:

The authors associate Epstein-Barr Virus (EBV) with various forms of cancer, and discuss methods and mechanisms of employing physical processes, for example, pointing out that activating cytotoxic T cells (CTL) has been shown effective. They also point to various difficulties in this approach, such as for treating nose and throat cancer in which the targets are not viable.

Health aspects, Care and treatment, Cell-mediated cytotoxicity, Cell mediated cytotoxicity, Epstein-Barr virus, Burkitt's lymphoma, Burkitt lymphoma, Nose cancer

---

Similar abstracts:

• Abstracts: Effect of highlay active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.